About Us
Company Values
- Honesty - we tell it as we see it
- Passion for building value and creating success - we are driven by the satisfaction of seeing value created from our work
- People-focused - we enjoy working with people, and take a mentoring and coaching attitude toward all of our interactions with you and your staff
Learn More
Our problem solving process is geared toward uncovering root causes, not just treating the symptoms. Our solution approach is holistic. We provide tools that last beyond the engagement and we train your staff on the underlying principles and thought processes to achieve sustainable results. Contact us to see if we are a good fit to your needs.
Vincent Chun, PhD
Managing Director
Dr. Vincent Chun has more than 15 years of experience advancing aerospace technologies for US military and civilian programs; and computational chemistry for rational drug development for the pharmaceutical industry. He also has another 15 years of experience in various business roles, including: management consultant at a global top tier firm, finance strategy and operations at a large technology corporation, and managing portfolio companies at a technology focused venture capital company. Vincent has a PhD in Aeronautics and Astronautics from Massachusetts Institute of Technology and an MBA from Kellogg School of Management. In his spare time, Vincent likes to travel, teaches tai chi, and hones his figure skating skills as an adult competitor and performer at ice skating shows.
Barbara Wan, PhD
Director
Dr. Barbara Wan has over 30 years of experience in pharmaceutical and biotech industries, specializing in project/program management. Her experience spans across multiple therapeutic areas (oncology, rare metabolic disease, ophthalmology and surgical adhesion prevention) in multiple modalities (small molecule, biologics, AAV delivery and medical devices).
Prior to becoming an independent consultant, she was VP, R&D Project Leadership at Cyteir Therapeutics, a clinical stage oncology company. Before joining Cyteir, she was VP, Program and Portfolio Management at Casebia Therapeutics, where she established and led the project management team covering gene-editing projects in ophthalmology, hematology, autoimmune diseases and CRISPR/Cas9 platform technology development. Barbara spent the bulk of her career at Genzyme (now part of Sanofi) where she conducted research for 10 years before transitioning to project management. As Senior Director, Project Management in the Biosurgical Business unit, she brought biomaterial-based medical devices from idea conception through development into commercialization. Barbara also managed post-approval commitments and other lifecycle management projects for Seprafilm®, Synvisc® and Epicel®. As Global Project Manager for Pompe Disease franchise, she worked closely with the Global Project Lead on initiating clinical trials for Nexviazyme®, a second- generation enzyme replacement therapy approved by FDA in 2021 for treatment of Pompe disease.
Barbara holds a PhD in Organic Chemistry from Brandeis University and is a certified Project Management Professional.